Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Director of Drug Substance Process Development at Amgen, USA
Art Hewig is a Director of Process Development at Amgen where he leads an integrated group that is designed to deliver end-to-end drug substance processes that robustly transfer to Amgen’s commercial network. Prior to the role Art was heading Purification Process Development at Amgen. Art has been with Amgen since 2002, where his initial focus was developing purification processes for early and late stage molecules. During this time he developed and implemented real time PAT technologies utilizing light scattering and as well as connected downstream processing. Art holds a PhD in Chemical Engineering from Carnegie Mellon University.